The global cardiac ablation technologies market size is expected to surpass USD 8.2 billion by 2027, this market is anticipated to grow with 11.8% CAGR during the forecast time period 2019 to 2026.
The global cardiac ablation technologies market is anticipated to be driven by technological advancements and increase in adoption of cardiac ablation technologies during the forecast period. The cardiac ablation technologies market in Asia Pacific is expected to expand at a high CAGR of 11.8% due to high prevalence of diseases, improvements in the health care sector, and increase in focus on research and development.
There are several factors such as growing elderly population that is combined with the rise in cardiovascular disease patients, technological advancements in the field of ablation devices, and rising awareness about several benefits of cardiac ablation procedures over conventional procedures which are fuelling the growth of the global cardiac ablation technologies market. But strict measures taken by several governments and constant healthcare reforms in the U.S. are major factors that can have an adverse effect on the growth of the cardiac ablation technologies market. Developing countries such as China, Mexico and India are the untapped growth opportunities for players that involved in engaged in manufacturing and distribution of cardiac ablation products. A number of factors such as increasing adoption of ablation in disease treatment, and rising market penetration of product manufacturers across various developing countries are offering growth opportunities for the key participants in the cardiac ablation technologies market.
The increase in awareness of least invasive procedures leads to increase in adoption as there is less pain and scars and it is also low-cost as compared to the traditional surgeries. There are various ablation techniques that are used in tissue removal. Negligibly aggressive surgeries are evolving as the possible substitute for the conventional therapeutic surgeries in treatment of numerous tumours of prostate, lungs and liver. Moreover, the introduction of advanced robotic technologies that is used in cardiac ablation process are safer and more accurate. Therefore, the rise in technological advancement in ablation devices is expected to create growth opportunities for cardiac ablation technologies market in the coming years.
Increase in geriatric population with rise in incidence of cardiac diseases drive market
The global population is aging rapidly, especially in some developed countries such as the U.S., most countries of Western Europe, and Japan. Developed countries witness a high rate of aging as compared to their developing counterparts. This is attributed to improved health care infrastructure, favorable reimbursement policies, and advancements in health care facilities in these countries. Moreover, access to various diagnostic and treatment services has improved in recent years, especially in developed countries. This, in turn, has increased the life expectancy of the population. The geriatric population is a major end-user for cardiac ablation technologies due to higher risk of developing cardiac diseases. Increase in the geriatric population leads to high rate of ailments, which in turn is likely to propel the demand for and consumption of cardiac ablation technologies.
Rising incidence of atrial fibrillation
It is estimated that around 33.5 million people worldwide are affected by atrial fibrillation, and the patient population is expected to rise substantially over the next several decades Rise in the prevalence rate of atrial fibrillation is creating a significant socioeconomic impact across the globe, which, in turn, propels the demand for ablation technologies.
Increase in patient preference for minimally invasive surgeries and technological advancement creates demand for cardiac ablation technologies
Cardiac ablation is minimal invasive procedure that destroys the affected heart tissue. These devices offer low complication rates and high technical success, leading to better quality of life for patients. Additionally, these devices are effective alternatives to invasive procedures. Minimally invasive procedures utilize advanced technology to reach the internal organs through small incisions, which cause less pain, low risk of infection, shorter hospital stays, quicker recovery time, less scarring, and reduced blood loss. These factors are likely to drive the global market in the near future. Furthermore, consistent involvement of key players in upgrade of the existing ablation products through research and development further boost the market.
The global cardiac ablation technologies market has been segmented based on technology type, application, and region. In terms of technology type, the market has been divided into radiofrequency, cryoablation, laser, ultrasound, microwave, and other. The radiofrequency segment accounted for around 56.0% share of the market, in terms of revenue, in 2017. Radiofrequency ablation procedure is a well-established procedure with high safety and efficacy, which leads to its higher adoption. Furthermore, it is a minimal invasive procedure, has low risk profile, and it is technically simple to perform, which further contributes to share held by the segment of the global market. Based on application, the market has been classified into atrial fibrillation, ventricular tachycardia, and others. The atrial fibrillation segment held a significant share of the market in 2017. It is expected to expand at a notable CAGR during the forecast period due to increasing incidence and prevalence of atrial fibrillation and rising adoption of cardiac ablation technologies for the treatment of atrial fibrillation. According to the American Heart Association (AHA), in 2013, there were around 2.7 million patients suffering from atrial fibrillation (AF) in the U.S., and is predicted to affect 6 to 12 million people by 2050. In the U.S., about 75% of atrial fibrillation (AF) patients are of 65 years of age or more. This indicates that a rise in the geriatric population is anticipated to boost the incidence and prevalence of AF.
Increase in prevalence of atrial fibrillation and other heart rhythm disorder in Asia Pacific to create opportunities in market
In terms of region, the global cardiac ablation technologies market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to hold a leading share of the global market during the forecast period, owing to high rate of adoption of cardiac ablation technologies and high health care expenditure. Europe is anticipated to account for a significant share of the global market between 2018 and 2026. Increase in incidence of atrial fibrillation and other heart diseases is expected to fuel the market in the region during the forecast period. The market in Asia Pacific is likely to expand considerably during the forecast period, due to a surge in health care expenditure. Moreover, increasing focus of key players on expansion in Asia Pacific, large untapped population, and rising awareness about health care boost the cardiac ablation technologies market in Asia Pacific. The cardiac ablation technologies market in Middle East & Africa is anticipated to expand at a steady pace between 2020 and 2027.
The key players catering to the global cardiac ablation technologies market are Medtronic Plc, St. Jude Medical, Inc. (Abbott), Olympus Corporation, Stryker Corporation, Alcon Laboratories Inc., MicroPort Scientific Corporation, Boston Scientific Corporation, CardioFocus Inc., and Biosense Webster, Inc. (Johnson & Johnson), Advanced Cardiac Therapeutics, and CONMED Corporation etc. These companies have established their prominent position in the global market and has huge customer base. They have diverse product offerings and an extensive distribution system of cardiac ablation products across the world. Moreover, the entrance of small companies, particularly in the developing markets of Asia Pacific, is being observed. However, strict government regulations and high-quality standards that set by market leaders are predicted to restrain the growth of new players in the global cardiac ablation technologies market. Important strategic initiatives undertaken by global companies include partnerships, new product launch, acquisitions, and mergers. Increasing investments on research and development activities coupled with technological advancements to commercialize highly efficient ablation products are estimated to offer lucrative growth opportunities for industry participants in the global cardiac ablation technologies market.
Market By Technology Type
Market By Application
Market By Geography
U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. In Vitro Diagnostics Market (By Product: Reagents, Instruments; By Technology: Immunoassay, Molecular Diagnostics; By Application: Infectious Diseases, Diabetes, Oncology, Cardiology; By End User: Hospitals, Laboratories, Home-care, Others) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. Clinical Trials Market (By Phase: Phase I, II, III, IV; By Study Design: Interventional, Observational; By Indication: Oncology, Diabetes) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Compounding Pharmacies Market (By Therapeutic Area: Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements; By Product: Oral, Liquid Preparations, Topical, Rectal, Others; By Application: Pediatric, Adult, Geriatric, Veterinary; By Compounding Type: PIA, CUPM, PDA; By Sterility: Sterile, Non-sterile; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030Read more...
Optical Imaging Systems Market (By Technology: Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy; By Product: Imaging Systems, Optical Imaging Software, Illumination Systems, Others; By Application: Pathological, Intraoperative; By End-use Outlook; By Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030Read more...